No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Parlodel (Bromocriptine) is a centrally acting dopamine agonist used to treat a variety of conditions related to the central nervous system. It is primarily used to treat Parkinson's disease, hyperprolactinemia, and pituitary tumors. It is also used to treat acromegaly, a condition caused by an overproduction of growth hormone. Parlodel is also used off-label to treat restless leg syndrome, a condition characterized by an irresistible urge to move the legs.
Parlodel is available in both oral and injectable forms. The oral form is taken once or twice daily, while the injectable form is administered once every two weeks. Common side effects of Parlodel include nausea, dizziness, and headaches.
The Parlodel market is a subset of the larger Central Nervous System Drugs market. This market is composed of a variety of drugs used to treat neurological conditions, including Parkinson's disease, Alzheimer's disease, and multiple sclerosis.
Some companies in the Parlodel market include Novartis, Teva Pharmaceuticals, and Mylan. Show Less Read more
